News

AlzeCure Publishes the Positive Clinical Results from the Phase I Trial of NeuroRestore ACD856 Against Alzheimer’s

STOCKHOLM, SWEDEN / ACCESSWIRE / August 9, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a…

1 year ago

Phonak Expands Lumity Portfolio, Empowering Kids and Adults With Various Types of Hearing Loss To Enjoy Conversations

New Sky, Naída and CROS address the unique needs of kids, teens, and adults. Lumity is now suitable for a…

1 year ago

Science & Humans (S&H) Welcomes Esteemed Canadian Endocrinologist & Geneticist Dr. Fady Hannah-Shmouni to Medical Advisory Board

MISSISSAUGA, ON / ACCESSWIRE / August 8, 2023 / Science & Humans (S&H), a health and wellness company focused on…

1 year ago

Model N Announces Third Quarter Fiscal Year 2023 Financial Results

Total Revenue Grew 13% Year-over-Year SaaS ARR Grew 28% Year-over-YearSAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in…

1 year ago

KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the…

1 year ago

Establishment Labs Reports Record Second Quarter 2023 Financial Results

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness,…

1 year ago

NHI Announces Second Quarter 2023 Results

MURFREESBORO, TN / ACCESSWIRE / August 8, 2023 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the…

1 year ago

NHI Announces Third Quarter 2023 Dividend

MURFREESBORO, TN / ACCESSWIRE / August 8, 2023 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay…

1 year ago

NHI Issues Investor Update

MURFREESBORO, TN / ACCESSWIRE / August 8, 2023 / National Health Investors, Inc. (NYSE:NHI) has issued the following investor update…

1 year ago

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023

Reports Net Revenues of $145.7 Million for the Three Months Ended June 30, 2023RANCHO CUCAMONGA, CA / ACCESSWIRE / August…

1 year ago